FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128493485> ?p ?o ?g. }

• W3128493485 endingPage "218" @default.
• W3128493485 startingPage "209" @default.
• W3128493485 abstract "Background: Epidermal Growth Factor Receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are responsible for several pathological conditions such as the development of different kinds of tumors. The combined inhibition of both signal transduction pathways seems to be a promising novel approach for cancer treatment. Methods: In this study, novel 4-anilinoquinazoline derivatives with various substituents on-7 position of quinazoline moiety were designed, synthesized, and evaluated for their antiproliferative activity against A431 and HU02 cell lines. Results: Compounds 8a, 8d, and 8f displayed the most potent anticancer activities against A431(IC50 = 1.78 μM, 8.25 μM, and 7.18 μM, respectively) in comparison with reference standards(erlotinib IC50=8.31 μM and vandetanib IC50=10.62 μM). Molecular docking studies proved that8a as the most potent compound could be efficiently accommodated in the ATP binding site ofEGFR and VEGFR-2 through the formation of essential hydrogen bonds between quinazolineN1 atom and the Met796 backbone of EGFR as well as the Cys919 backbone of VEGFR-2 with a distance of 1.94 Å and 1.398 Å, respectively. Conclusion: Compound 8a as the most potent compound with morpholine and 3-bromoaniline at the 7 and 4 positions of quinazoline scaffold, respectively, deserves more study and structural optimization as an anticancer agent." @default.
• W3128493485 created "2021-02-15" @default.
• W3128493485 creator A5034290284 @default.
• W3128493485 creator A5034389700 @default.
• W3128493485 creator A5059686313 @default.
• W3128493485 creator A5068970539 @default.
• W3128493485 date "2020-10-02" @default.
• W3128493485 modified "2023-09-30" @default.
• W3128493485 title "<b>6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents</b>" @default.
• W3128493485 cites W1422195457 @default.
• W3128493485 cites W1538925875 @default.
• W3128493485 cites W1971271442 @default.
• W3128493485 cites W1984375602 @default.
• W3128493485 cites W1985362629 @default.
• W3128493485 cites W2001289665 @default.
• W3128493485 cites W2014938747 @default.
• W3128493485 cites W2018711732 @default.
• W3128493485 cites W2024447293 @default.
• W3128493485 cites W2028409520 @default.
• W3128493485 cites W2028415754 @default.
• W3128493485 cites W2056259571 @default.
• W3128493485 cites W2058413420 @default.
• W3128493485 cites W2082298210 @default.
• W3128493485 cites W2094891204 @default.
• W3128493485 cites W2109884288 @default.
• W3128493485 cites W2130614628 @default.
• W3128493485 cites W2152081474 @default.
• W3128493485 cites W2162969728 @default.
• W3128493485 cites W2177929699 @default.
• W3128493485 cites W2314636221 @default.
• W3128493485 cites W2416222571 @default.
• W3128493485 cites W2519105450 @default.
• W3128493485 cites W2887037320 @default.
• W3128493485 cites W2964007958 @default.
• W3128493485 cites W3007877657 @default.
• W3128493485 cites W3021418179 @default.
• W3128493485 doi "https://doi.org/10.34172/ps.2020.72" @default.
• W3128493485 hasPublicationYear "2020" @default.
• W3128493485 type Work @default.
• W3128493485 sameAs 3128493485 @default.
• W3128493485 citedByCount "5" @default.
• W3128493485 countsByYear W31284934852021 @default.
• W3128493485 countsByYear W31284934852022 @default.
• W3128493485 crossrefType "journal-article" @default.
• W3128493485 hasAuthorship W3128493485A5034290284 @default.
• W3128493485 hasAuthorship W3128493485A5034389700 @default.
• W3128493485 hasAuthorship W3128493485A5059686313 @default.
• W3128493485 hasAuthorship W3128493485A5068970539 @default.
• W3128493485 hasBestOaLocation W31284934851 @default.
• W3128493485 hasConcept C155647269 @default.
• W3128493485 hasConcept C159110408 @default.
• W3128493485 hasConcept C170493617 @default.
• W3128493485 hasConcept C185592680 @default.
• W3128493485 hasConcept C2777506169 @default.
• W3128493485 hasConcept C2778087573 @default.
• W3128493485 hasConcept C2778866207 @default.
• W3128493485 hasConcept C2779438470 @default.
• W3128493485 hasConcept C2780333294 @default.
• W3128493485 hasConcept C2780580887 @default.
• W3128493485 hasConcept C2781056017 @default.
• W3128493485 hasConcept C41685203 @default.
• W3128493485 hasConcept C42362537 @default.
• W3128493485 hasConcept C55493867 @default.
• W3128493485 hasConcept C62478195 @default.
• W3128493485 hasConcept C71240020 @default.
• W3128493485 hasConcept C71924100 @default.
• W3128493485 hasConceptScore W3128493485C155647269 @default.
• W3128493485 hasConceptScore W3128493485C159110408 @default.
• W3128493485 hasConceptScore W3128493485C170493617 @default.
• W3128493485 hasConceptScore W3128493485C185592680 @default.
• W3128493485 hasConceptScore W3128493485C2777506169 @default.
• W3128493485 hasConceptScore W3128493485C2778087573 @default.
• W3128493485 hasConceptScore W3128493485C2778866207 @default.
• W3128493485 hasConceptScore W3128493485C2779438470 @default.
• W3128493485 hasConceptScore W3128493485C2780333294 @default.
• W3128493485 hasConceptScore W3128493485C2780580887 @default.
• W3128493485 hasConceptScore W3128493485C2781056017 @default.
• W3128493485 hasConceptScore W3128493485C41685203 @default.
• W3128493485 hasConceptScore W3128493485C42362537 @default.
• W3128493485 hasConceptScore W3128493485C55493867 @default.
• W3128493485 hasConceptScore W3128493485C62478195 @default.
• W3128493485 hasConceptScore W3128493485C71240020 @default.
• W3128493485 hasConceptScore W3128493485C71924100 @default.
• W3128493485 hasIssue "2" @default.
• W3128493485 hasLocation W31284934851 @default.
• W3128493485 hasOpenAccess W3128493485 @default.
• W3128493485 hasPrimaryLocation W31284934851 @default.
• W3128493485 hasRelatedWork W2098943804 @default.
• W3128493485 hasRelatedWork W2114008301 @default.
• W3128493485 hasRelatedWork W2127734710 @default.
• W3128493485 hasRelatedWork W2132527333 @default.
• W3128493485 hasRelatedWork W2150335765 @default.
• W3128493485 hasRelatedWork W2337170247 @default.
• W3128493485 hasRelatedWork W2569400214 @default.
• W3128493485 hasRelatedWork W3042093143 @default.
• W3128493485 hasRelatedWork W3128493485 @default.
• W3128493485 hasRelatedWork W4362558909 @default.
• W3128493485 hasVolume "27" @default.

• next